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Low doses of LPS exacerbate the
inﬂammatory response and trigger death
on TLR3-primed human monocytes
Marta Monguió-Tortajada1,2, Marcella Franquesa1,3, Maria-Rosa Sarrias4,5 and Francesc E. Borràs1,2,3
Abstract
TLR sensing of pathogens triggers monocyte activation to initiate the host innate immune response to infection.
Monocytes can dynamically adapt to different TLR agonists inducing different patterns of inﬂammatory response, and
the sequence of exposure to TLRs can dramatically modulate cell activation. Understanding the interactions between
TLR signalling that lead to synergy, priming and tolerance to TLR agonists may help explain how prior infections and
inﬂammatory conditioning can regulate the innate immune response to subsequent infections. Our goal was to
investigate the role of MyD88-independent/dependent TLR priming on modulating the monocyte response to LPS
exposure. We stimulated human blood monocytes with agonists for TLR4 (LPS), TLR3 (poly(I:C)) and TLR7/8 (R848) and
subsequently challenged them to low doses of endotoxin. The different TLR agonists promoted distinct inﬂammatory
signatures in monocytes. Upon subsequent LPS challenge, LPS- and R848-primed monocytes did not enhance the
previous response, whereas poly(I:C)-primed monocytes exhibited a signiﬁcant inﬂammatory response concomitant
with a sharp reduction on cell viability. Our results show that TLR3-primed monocytes are prompted to cell death by
apoptosis in the presence of low endotoxin levels, concurrent with the production of high levels of TNFα and IL6. Of
note, blocking of TNFR I/II in those monocytes did reduce TNFα production but did not abrogate cell death. Instead,
direct signalling through TLR4 was responsible of such effect. Collectively, our study provides new insights on the
effects of cross-priming and synergism between TLR3 and TLR4, identifying the selective induction of apoptosis as a
strategy for TLR-mediated host innate response.
Introduction
Monocytes, as key actors of the innate immunity, are
equipped with a wide range of pathogen recognition
receptors (PRRs) to initiate host defence responses against
invading pathogens. Among PRRs, speciﬁc Toll-like
receptors (TLRs) located in the cell membrane and
endosomal compartments sense different components of
microorganisms known as pathogen-associated molecular
patterns1. Activation of TLRs triggers direct antimicrobial
activity together with distinct inﬂammatory patterns
depending on the TLR agonist encountered, which
modulates the posterior adaptive immune response. Upon
agonist engagement, TLRs can follow two main signalling
pathways depending on the adaptor molecule recruited to
the TIR domains of the TLRs that initiates the intracel-
lular cascade2. The myeloid differentiation factor 88
(MyD88)-dependent pathway, which is used by all TLRs
except for TLR3, leads to early activation of NFκB for
inﬂammatory cytokine production, specially TNFα by
monocytes/macrophages. Instead, viral dsRNA-sensing
TLR3, and also TLR4, use the MyD88-independent sig-
nalling through the Toll-IL1 domain-containing adaptor
inducing IFN-β (TRIF), which activates IRF3 and IRF7 to
produce type-I IFN as an antiviral innate response3,4.
© The Author(s) 2018
OpenAccessThis article is licensedunder aCreativeCommonsAttribution 4.0 International License,whichpermits use, sharing, adaptation, distribution and reproduction
in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if
changesweremade. The images or other third partymaterial in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to thematerial. If
material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Correspondence: Francesc E. Borràs (feborras@igtp.cat)
1REMAR-IVECAT Group, Health Science Research Institute Germans Trias i Pujol,
Can Ruti Campus, Badalona, Spain
2Department of Cell Biology, Physiology and Immunology, Universitat
Autònoma de Barcelona, Bellaterra, Spain
Full list of author information is available at the end of the article
Edited by T Kaufmann
Ofﬁcial journal of the Cell Death Differentiation Association
12
34
56
78
90
()
:,;
12
34
56
78
90
()
:,;
Therefore, gram-negative bacterial lipopolysaccharide
(LPS)-sensing TLR4 is the only TLR that has been
described to signal through both pathways. At the same
time, it is still unclear whether the proﬁles of TLR
responses are exclusively determined by the adaptor
molecule they use, as the two main signalling pathways
can interact and yield more complex phenotypes.
Monocytes can adapt to infection, and inﬂammatory
conditioning can lead to transient memory states. For
instance, continuous TLR4 activation with repeated
exposure to bacterial LPS, such as in sepsis, promotes
hyporesponsiveness of monocytes to subsequent LPS
challenge, a phenomenon termed endotoxin tolerance5–7.
Moreover, previous studies have shown that different TLR
agonists interplay to modulate the inﬂammatory response
to each other4,8–10, synergizing to enhance the immune
response or promoting heterotolerance to restrain
inﬂammation instead. Understanding the interactions
between TLR signalling that lead to synergy, priming and
tolerance to TLR agonists may help explain monocyte
plasticity and how prior infections and inﬂammatory
conditioning can modulate the innate immune response
to secondary infections or co-infections.
We studied the effect of TLR priming of TLR4 (LPS),
MyD88-dependent TLR7/8 (using synthetic analogue for
single-stranded RNA R848), and MyD88-independent
TLR3 (using synthetic analogue for double-stranded
RNA poly(I:C)) on the inﬂammatory response of mono-
cytes to subsequent challenge of TLR4. Our results show
that the sequential stimulation of TLR3 and TLR4 leads to
the exacerbation of the inﬂammatory response of mono-
cytes together with the triggering of cell death, which is
directly dependent on TLR4 signalling but independent
from TNFα.
Results
TLR agonists lead to distinct monocyte response
signatures
Monocytes were cultured for 24 h in non-stimulated
conditions or stimulated with TLR agonists LPS (TLR4,
100 ng/ml), poly(I:C) (TLR3, 50 µg/ml) or R848 (TLR7/8,
2.5 µM). While all TLR ligands prompted cell activation
(Fig. 1a, b), the activation signature was different
depending on the TLR ligand used for monocyte stimu-
lation. LPS induced an increased expression of CD14 and
CD25, while poly(I:C) induced a marked upregulation of
Fig. 1 TLR agonists lead to distinct monocyte response signatures. Monocytes were stimulated for 24 h with ligands for TLR4 (LPS), -3 (poly(I:C))
or -7/8 (R848) and checked for cell activation. a Monocytes (distinguished by FSC-A/SSC-A) were analyzed for CD14, CD25, CD80, CD83 and CD86
expression by ﬂow cytometry and the MFI values of monocytes are shown. The data are mean ± SD and accounts for more than six independent
experiments. b TNFα, IL6, IL8, IL10 and IL1β levels found in culture supernatants of monocytes cultured with TLR agonists for 24 h. The data are mean
± SD and accounts for more than four independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001 by Kruskall–Wallis with Dunn’s
post-hoc test
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CD86, and R848 induced specially CD25, and also CD80
and CD83 (Fig. 1a). In terms of cytokine production,
MyD88-dependent TLRs resembled each other, as LPS
and R848 quickly triggered the secretion of TNFα, IL6,
IL8, IL10 and IL10β, while poly(I:C) did not (Fig. 1b).
TLR3 priming synergizes with low dose TLR4 for an
increased inﬂammatory response by monocytes
The inﬂuence of different TLR agonist priming on
modulating a secondary TLR4 response by monocytes was
then assessed. After 24 h of culture with a ﬁrst TLR
agonist, monocytes were challenged with a low dose LPS
(0.2 ng/ml), and 5 h later, cells were collected to analyze
their short-term inﬂammatory response. Monocytes that
had been primed with LPS did not increase their activa-
tion markers expression nor their cytokine production
after LPS challenge (Fig. 2a, b). R848-primed monocytes
were unchanged in terms of activation markers expression
but signiﬁcantly increased their secretion of IL8 and IL10,
although they were already produced in great amounts
before the LPS challenge (Fig. 2b). On the other hand,
monocytes that had been previously stimulated with poly
(I:C) boosted their CD83 expression in the same way as
non-primed cells (Fig. 2a), and noticeably, only poly(I:C)-
primed monocytes exacerbated the pro-inﬂammatory
cytokine production of TNFα and IL6 after the low dose
LPS challenge (Fig. 2b). Given the sudden and marked
increase on TNFα and IL6, known inducers of inﬂam-
mation, we sought to study more these cross-primed
monocytes.
Secondary LPS exposure causes cell death to non-primed
and TLR3-primed monocytes
To further delineate cellular state and activation, cell
viability was monitored by evaluating both mitochondrial
function and membrane integrity by ﬂow cytometry. As
depicted in Fig. 3a, viable cells were gated according to
their functional mitochondrial transmembrane potential
(DiOC6(3)+) and no permeability to propidium iodide
(PI−). While non-stimulated monocytes and R848-
activated monocytes displayed a reduced viability after
24 h in culture, LPS and poly(I:C) activation rescued
monocytes from in vitro cell death (Fig. 3b, c).
We then studied the viability of monocytes after low
dose LPS challenge. LPS addition did not modify mono-
cyte viability when the previous stimuli were LPS or R848,
but resulted in a reduction in cell viability of non-primed
monocytes (−22.4%; Fig. 3d), and importantly on TLR3-
primed monocytes (−43.3%). Interestingly, non-primed
monocytes heterogeneously responded to LPS-induced
cell death (Fig. 3e, left), but poly(I:C) priming consistently
committed monocytes from different donors to cell death
in a dose-dependent response to low dose LPS challenge
(Fig. 3e, right). Even extremely low endotoxin levels (0.02
ng/ml LPS) were already able to induce a 27.6% of cell
death, and higher concentrations (0.2 and 2 ng/ml LPS)
both triggered the death of around the half of the
monocyte population (43.3% and 45.4%, respectively). On
the contrary, when the combination of TLR agonists was
inverted, so LPS-primed monocytes were stimulated with
poly(I:C), it did not lead to cell death nor increased cell
activation (data not shown).
A kinetics study with shorter time points showed the
rapid and consistent decrease in poly(I:C)-primed
monocyte viability after LPS stimulation (Fig. 4a). In an
attempt to distinguish whether cell death or cell activation
was triggered ﬁrst, we analysed NFκB activation by
quantifying RELA translocation, 30 min after LPS stimu-
lation of non-primed and poly(I:C)-primed monocytes. A
23.8% ± 11.8% of non-stimulated, poly(I:C)-primed
monocytes had nuclear RELA (Fig. 4b, c), indicative of
NFκB activation after 24 h of poly(I:C) addition. After 30
min of LPS addition (0.2 ng/ml), NFκB activation occur-
red in the vast majority of cells regardless of the priming
state of monocytes (84.2% ± 6.8% non-primed and 90.4%
± 0.8% poly(I:C)-primed). NFκB activation also correlated
with an early upregulation of CD83 surface expression
(Fig. 4d), the marker that was previously shown to be
increased at 5 h post-LPS addition (Fig. 2a). Altogether,
these results seem to indicate that cell activation and cell
death happen concomitantly.
LPS triggers apoptosis on TLR3-primed monocytes
Given this profound effect on cell viability, we next
explored which type of cell death was triggered by low
dose LPS on poly(I:C)-primed monocytes (Fig. 5a). The
descent in the percentage of viable cells according to only
PI labelling was similar for both non- and poly(I:C)-
primed monocytes (Fig. 5b), suggesting that necrosis was
not fostered. The difference between the two priming
conditions was actually found when the monocytes’
mitochondrial function was analyzed. An increase in cell
death according to DiOC6(3) staining in poly(I:C)-primed
monocytes compared to non-primed monocytes was
observed already at 5 h after LPS addition (Fig. 5b).
As these results were suggestive of apoptosis induction,
we next examined the effect of the pan-caspases inhibitor
Z-VAD-fmk on the viability of monocytes. The addition
of Z-VAD-fmk prevented the cell death fostered by poly(I:
C) priming of monocytes after sequential LPS exposure
(Fig. 5c), indicating thus an apoptotic cell death of
monocytes sequentially activated with poly(I:C) and LPS.
To further discard caspase-independent types of pro-
grammed cell death, necrostatin-1 (Nec-1) was added to
cell culture. Programmed necrosis or necroptosis has
been identiﬁed also in monocytes11,12. Necroptosis sig-
nalling involves the activation of the kinase domain of
receptor-interacting protein 1 (RIP1), which can be
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Fig. 2 TLR3 priming synergizes with low dose TLR4 for an increased inﬂammatory response by monocytes. Monocytes were primed or not
for 24 h with LPS, poly(I:C) or R848, then challenged with (blue bar) or without (white bar) with 0.2 ng/ml LPS for 5 h. a The surface expression of
CD14, CD25, CD80, CD83 and CD86 were checked by ﬂow cytometry (monocytes distinguished by FSC-A/SSC-A). The data are mean MFI ± SD
relative to each control (non-stimulated monocytes) and accounts for more than three independent experiments. b TNFα, IL6, IL8, IL10 and IL1β
levels found in culture supernatants of monocytes after LPS challenge. Data is mean ± SD and accounts for four independent experiments. Statistical
differences towards LPS response are shown as *p < 0.05; **p < 0.01 by two-way ANOVA
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speciﬁcally inhibited with Nec-113. Our results showed
that poly(I:C)/LPS-induced cell death was not prevented
when cells were pre-incubated with Nec-1 (Fig. 5c), dis-
carding a necroptotic cell death. Moreover, pyroptosis
could also be ruled out as IL1β—a crucial cytokine in this
process—was not produced by poly(I:C)/LPS-stimulated
monocytes (Fig. 2b).
LPS promotes apoptosis independently of TNFα
production but downstream of TLR4 signalling in TLR3-
primed monocytes
We next studied possible inducers of the apoptosis
promoted by LPS in TLR3-primed monocytes (Fig. 6a).
One of the classical triggers of apoptosis is the signalling
through TNF receptors. While TNFα was not produced in
poly(I:C)-stimulated monocytes (Fig. 2b), these cells pro-
duced high levels of TNFα in a dose-dependent manner
upon LPS challenge (Fig. 6b). TNFα production was
enhanced by two-fold by poly(I:C) priming compared to
non-primed cells (Fig. 6b). The levels of TNFα produced
were as low as non-primed cells when apoptosis was
blocked by treating poly(I:C)-primed monocytes with Z-
VAD-fmk before LPS addition (Fig. 6c). The addition of
neutralizing antibodies for TNFRI and TNFRII dimin-
ished the production of TNFα by half when both were
used (Fig. 6d), but could not inhibit the death induced by
LPS challenge to poly(I:C)-primed monocytes (Fig. 6e).
Noticeably, TNFα production was abrogated by block-
ing speciﬁcally TLR4 signalling with TAK242 (Fig. 6f).
The use of this TLR4 antagonist directly correlated with
the complete inhibition of LPS-induced cell death
(Fig. 6g). All together, these results suggested the direct
association between TLR4 ligation and signalling with the
induction of cell death by LPS, and ruled out a TNFR-
dependent induction of apoptosis in TLR3-primed
monocytes.
Further insight on the central role of LPS ligation in the
TLR3-primed monocyte-induced cell death and activation
was obtained when blocking LPS traces with polymyxin B
(PmxB). PmxB was simply mixed with LPS before its
addition to monocytes, and while it was innocuous by
itself, it successfully inhibited the LPS-induced cell death
(Fig. 7a), and also the inﬂammatory cytokine production
of TNFα, IL6 and IL8 in TLR3-primed monocytes
(Fig. 7b).
Discussion
The present study reports that TLR3 priming boosted
the inﬂammatory response of human monocytes to sub-
sequent low dose LPS challenge, with a concomitant and
drastic apoptotic cell death of half the monocyte
population.
Studies before have shown the interplay between TLR
signalling pathways, leading to distinct transcriptional and
thus phenotypic proﬁles that might be not simply classi-
ﬁed as MyD88-dependent or independent14. For instance,
TLR3 has been reported to indirectly activate NFκB1,15,16,
as we have also observed. Nevertheless, the classiﬁcation
and study of TLR responses according to their intracel-
lular signalling adaptors greatly deﬁnes monocyte
response to TLR ligation, as we described here and others
have observed1,34,17. In our hands, monocytes stimulated
with agonists for MyD88-dependent TLRs (LPS-TLR4
and R848-TLR7/8, summarized in Fig. 8a) showed iden-
tical proﬁles of inﬂammatory cytokine secretion, while the
activation phenotype revealed some speciﬁc features
depending on the TLR agonist used. However, TLR3
priming did not produce inﬂammatory cytokine secretion.
The observed absence of inﬂammatory cytokine produc-
tion after single TLR3 stimulation has been observed
before4,8, and it could be explained by the single signalling
of TRIF towards IRF3/7 activation, with a minor TRAF6
co-activation of NFκB (Fig. 8a). At the same time, timing
of TLR responses could be different between the two
signalling pathways. Yet, poly(I:C) promoted monocyte
activation and priming, shown by the CD86 upregulation,
NFκB nuclear translocation, increased survival compared
to control conditions and exacerbated response to sec-
ondary low dose LPS stimulation.
At the same time, recognition of viral RNA is not
exclusive of TLR3, as it has been described before to be
recognised by the cytoplasmic RNA helicases, retinoic
acid inducible gene-I (RIG-I), that binds to short dsRNA
Fig. 5 LPS triggers apoptosis on TLR3-primed monocytes. a
Schematics of the experimental design followed. b Relative viability of
non-primed (left) or poly(I:C)-primed (right) monocytes after 0.2 ng/ml
LPS challenge, measured either as the % of non-apoptotic cells (DiOC6
(3)+/PI−) or non-necrotic cells (PI-). c Relative viability (%DiOC6(3)+/
PI−) of non-primed or poly(I:C)-primed monocytes with or without
pre-incubation with the pan-caspases inhibitor Z-VAD-fmk (50 µM; n
= 8) or the RIP1 inhibitor Necrostatin-1 (Nec-1; 90 µM; n= 5). The data
are expressed as mean ± SD, relative to each control, and accounts for
more than four independent experiments. Statistical differences are
indicated for *p < 0.05 by two-way ANOVA and #p < 0.05; ##p < 0.01;
####p < 0.0001 by one-sample T-test
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(<1000 bp) and 5′-triphosphate single-stranded RNA (5′-
PPP-RNA), and melanoma differentiation-associated gene
5 (MDA-5), which detects long dsRNA (>1000 bp)18–20.
The data on human monocyte-derived macrophages
indicates that they do express MDA-5 but lack RIG-I21.
High-molecular weight poly(I:C), which is the one used in
our experiments, has been shown to be detected pre-
ferentially by TLR3 when added to the culture medium,
while it needs to be actively delivered to the cytosol to
promote MDA-5 detection by means of transfec-
tion20,22,23, and only after shortening to further signal
through RIG-I18. Furthermore, response to poly(I:C)
greatly differs when detected by TLR3 compared to
MDA-5, given that great amounts of IFNβ and TNFα are
produced after transfection of poly(I:C) and thus detected
by MDA-5, but not when it is added to the culture
medium and detected instead by TLR324. Therefore, in
our case, as poly(I:C) is simply added to the culture
medium and no TNFα was detected after its addition, it
all would indicate TLR3 ligation rather than signalling
through MDA-5 is happening.
The heightened response to sequential LPS exposure is
particularly relevant given the low doses of LPS used.
These observations can have implications in the patho-
logical context, and may also be signiﬁcant in vitro. In this
sense, recombinant proteins and serum-derived products
can contain minimal amounts of LPS, which even referred
as “endotoxin-free,” could be altering results by activating
monocytes. In fact, previous studies showed already how
these same very low doses of LPS (as little as 0.2 EU/ml)
can induce inﬂammatory cytokine production by human
monocytes and dendritic cells25. As we show in the pre-
sent study, adding PmxB to the reagent of choice could be
an efﬁcient and easy precautious method to avoid
experiment artefacts.
Monocyte response to combined TLR ligation can result
both in synergy and tolerance, yielding induction or
restriction of inﬂammation respectively, to ﬁne-tune the
innate and adaptive immune responses. This equilibrium
has actually been the focus of study before, especially in
the context of sepsis, in which endotoxin tolerance is a
hallmark of this disease6,7,26. “Endotoxin tolerance” refers
to the refractory state to LPS challenge that innate cells,
including monocytes, have after repeated LPS exposure.
Both the timing and the dose of LPS were proven to be
crucial to induce either priming or tolerance of TLR4
response. Yuan et al.9 showed how high doses of LPS were
responsible of hyporesponsiveness to LPS challenge, but
low LPS doses induced a low-level inﬂammatory state on
murine macrophages. Our results suggest that monocytes
do not suffer major changes after repeated LPS exposure,
as they kept on expressing activation markers and pro-
ducing high amounts of inﬂammatory cytokines, probably
due to insigniﬁcant change on overall LPS concentration.
When using combinations of different TLRs, temporal
and sequential TLR activation may also produce synergy
or tolerance. For instance, Napolitani et al. showed
maximal synergy between TLR4 and TLR8 in human
monocyte-derived dendritic cells when they were given in
a 4-hour window regardless of the order, while TLR3 and
TLR8 response was enhanced uniquely when poly(I:C)
was added before R848 and not otherwise27. Bagchi and
colleagues combined MyD88-dependent and independent
TLR agonists and while some combinations yielded cross-
tolerance, they found that poly(I:C) priming and second-
ary TLR2 (MyD88-dependent) or TNF activation pro-
moted cross-priming of murine macrophages4, although
only the cytokine proﬁle was analysed.
In line with these reports, we describe how the
sequential exposure of human monocytes to TRIF-
Fig. 7 PmxB abrogates LPS-mediated apoptosis and cytokine production in TLR3-primed monocytes. PmxB was mixed with LPS before its
addition to poly(I:C)-primed monocytes. a Relative viability of monocytes after 5 h of LPS challenge. b Inﬂammatory cytokine levels (TNFα, IL6 and IL8)
found in culture supernatants of poly(I:C)-primed monocytes challenged with LPS or LPS pre-incubated with PmxB. The data are mean ± SD of three
independent experiments. ####p < 0.0001 by one-sample T-test; *p < 0.05 and **p < 0.01 by Kruskall–Wallis with Dunn’s post-hoc test
Monguió-Tortajada et al. Cell Death and Disease  (2018) 9:499 Page 9 of 14
Ofﬁcial journal of the Cell Death Differentiation Association
(TLR3) and TRIF/MyD88-dependent (TLR4) agonists
resulted in the augmented inﬂammatory response to the
second agonist, leading to the cross-priming of monocytes
towards a drastic activation of cells, while the inverted
combination of TLR agonists did not. Although TLR3 is
designed to mount an antiviral immune response after
sensing dsRNA (a replication intermediate of several
virus), and TLR4 would promote cell activation upon
gram-negative bacteria detection, synergy between TLR3
and TLR4 has been proven before to successfully
Fig. 8 Schematic representation of the TLR signalling pathways and results. a Overview of the signalling pathways involved in the TLRs studied.
Upon R848 or ssRNA ligation, TLR7/8 uses the adaptor molecule MyD88 to signal through TRAF6 and activate the transcription factors inducing
inﬂammatory cytokine production. Poly(I:C) or dsRNA bind to TLR3, that uses the adaptor molecule TRIF to activate TRAF3 and produce type I IFNs to
initiate an antiviral immune response. It can also activate TRAF6. TLR4, recognizing LPS with the help of MD2 and CD14, is the only TLR that can signal
through both MyD88 and TRIF. b Stimulation of monocytes with poly(I:C) increased their viability and expression of CD86 (1). When poly(I:C)-primed
monocytes were then stimulated with low doses of LPS, NFκB signalling was activated and translocated to the nucleus (2), they upregulated CD83
expression, and boosted TNFα and IL6 production (3), concomitant with death by apoptosis (blocked by Z-VAD-fmk) of half the population (4). These
effects were inhibited by TAK242, indicating the dependence on direct signalling through TLR4. The induced cell death caused the increased TNFα
production (5)
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cooperate against infection. For instance, systemic acti-
vation of TLR3/TRIF promotes resolution of gram-
negative gut infection28, while antiviral response is
worse in TLR4 knockout mice29. Also, TNFα production
—which quickly spiked after the sequential TLR3–TLR4
activation of monocytes—contributes to virus clearance in
the ﬁrst stages of a viral infection30.
The effect of TLR signalling on monocyte biology is
normally focused on the activation response of cells, while
viability of cells is often overlooked. In our experiments,
TLR4-activation of TLR3-primed monocytes was con-
comitant with the apoptotic cell death of half the popu-
lation (as summarized in Fig. 8b) as determined by
mitochondrial membrane function, a highly sensitive and
stringent method to measure early apoptotic cell death31–
33.
TLR3-primed monocytes apoptotic cell death was most
probably due to the activity of pre-mitochondrial cas-
pases given that pan-caspases inhibitors were able to
abrogate the loss of mitochondrial potential. Apoptosis
has been shown before to be induced directly through
LPS-TLR4 signalling34,35. As little as 1 ng/ml has been
demonstrated to trigger necrotic and apoptotic monocyte
death36 and intrinsic and extrinsic apoptosis in the
monocytic cell line THP-137. Indeed, Liu and colleagues
demonstrated the involvement of the mitochondrial
apoptotic pathway in LPS-related death, although in their
model apoptosis could be prevented by blocking TNFR.
In our case, TNFα production spiked after LPS challenge
in TLR3-primed human peripheral blood monocytes,
caused by apoptosis of cells, and blockade of TNFR
ligation did not rescue cells from death. Instead, mono-
cyte death was depending on direct triggering of
TLR4 signalling cascade as proven by direct and speciﬁc
blockage with TAK24238–40. These results seem to dis-
card the involvement of other than TLR4 for LPS
detection, such as cytoplasmic PRRs41. Similarly, the
absence of IL1β and the fact that Nec-1 did not prevent
cell death ruled out the induction of, pyroptosis42,43 and
necroptosis44, respectively.
In the context of infection, apoptotic cell death is a well
known antiviral mechanism for the host to eliminate
virus-infected cells. The combination of the boosted
inﬂammatory cytokine production with the TLR4-
dependent death that we describe may enhance the anti-
viral response of host monocytes by triggering an
inﬂammatory immune response and rapidly eliminating
infected cells to stop virus spread45,46. This secondary
activation with LPS could be happening in the case of co-
infection of bacteria and virus or also in the presence of
sub-clinical pathology. Given the low doses of LPS needed
to elicit this effect, residual endotoxin presence would be
enough to trigger these effects in the context of viral
infection alone. Also, in the immediacy of an
inﬂammatory site, LPS leakage or translocation can occur
from a localized infection to the bloodstream, and affect
circulating monocytes47,48, as in Inﬂammatory Bowel
Disease or Cystic Fibrosis47,49–51.
In summary, the sequential collaboration of TLR3 and
TLR4 to boost the inﬂammatory cytokine secretion of
human monocytes, concomitant with the drastic trigger-
ing of cell death, may be a novel strategy for TLR-
mediated host innate response to ﬁght pathogen spread
after infection.
Materials and methods
Monocyte isolation and culture
The study protocols were approved by the Clinical
Research Ethics Committee of our institution (Comitè
Ètic d’Investigació Clínica, HuGTiP, Ref. CEIC: PI−13-
011), and conformed to the principles outlined in the
Declaration of Helsinki.
Peripheral blood monocytes were obtained from leu-
cocyte residues from healthy donors provided by the
Blood and Tissue Bank (Barcelona, Spain). Succinctly,
peripheral blood mononuclear cells were depleted of
CD3+ cells using the RosetteSepTM Human CD3 Deple-
tion Cocktail (StemCell Technologies, Seattle, WA)
during a Ficoll-Paque density centrifugation (GE
Healthcare, Uppsala, Sweden) and monocytes were then
positively selected by MagniSort™ Human CD14 Positive
Selection Kit (eBioscience, San Diego, CA), as recom-
mended by the manufacturer. Monocytes were assessed
for purity by CD14-FITC staining (BD, San Jose, CA),
obtaining >95% CD14+ cells analysed in a Canto II ﬂow
cytometer (BD).
Culture medium comprised RPMI 1640 medium sup-
plemented with 100 µg/ml streptomycin, 100 IU/ml
penicillin and 5% heat-inactivated human AB serum
(H4522, Sigma, St Louis, MO). Cells were counted using
PerfectCount Microspheres (Cytognos, Salamanca, Spain)
and viability was >94% as determined by 7-AAD exclusion
by ﬂow cytometry (FACSCanto II, BD).
Cell stimulation
Cells were seeded in 96-well ﬂat-bottomed plates at 1 ×
106 cells/ml and were ﬁrst stimulated with TLR agonists:
100 ng/ml LPS (Escherichia coli O111:B4; Sigma), 50 µg/
ml poly(I:C) (High-molecular weight; Invivogen, San
Diego, CA) or 2.5 µM R848 (Alexis Biochemicals, San
Diego, CA) as indicated for each experiment. After 24 h,
low doses of LPS were added to monocytes (0.02, 0.2 or 2
ng/ml) and supernatant and cells were collected 5 h later,
or else as indicated, to assess cytokine secretion, viability
and cell activation phenotype.
Alternatively, PmxB (2 µg/ml; Sigma) was mixed with
LPS before its addition to monocytes, incubated for 30
min at 37 °C.
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Cytokine measurement
Cell supernatants were collected, cleared of debris by
centrifuging at 400 g 5min and kept at −20 °C. The levels
of cytokines were measured by ELISA following the
manufacturers’ instructions: IL6, IL8 were purchased
from ImmunoTools (Friesoythe, Germany), IL10 and
TNFα from U-Cytech (Utrecht, The Netherlands) and
IL1β from R&D Systems.
Cell activation phenotype
Monocytes were stained with ﬂuorochrome-conjugated
antibodies CD14-FITC, CD25-PE-Cy5, CD83-APC (BD)
and CD80-PEVio770 and CD86-PE (Miltenyi Biotech,
Bergisch Gladbach, Germany) for 15min at room tem-
perature, washed with PBS and analysed in a Canto II ﬂow
cytometer (BD).
Cell death assessment
To assess the type of cell death, cells were pre-incubated
with the pan-caspases inhibitors Z-VAD-fmk, Q-VD-oPH
(50 µM and 20 µM after titration analysis; Sigma), the RIP1
inhibitor Nec-1 (90 µM; Sigma), the neutralizing antibodies
against TNFRI and TNFRII (clones 16803 and 22221; R&D
Systems, Abington, UK) or the TLR4 signalling inhibitor
TAK242 (Calbiochem, San Diego, CA), which were added
30min prior to secondary, low dose (0.02, 0.2 or 2 ng/ml)
LPS stimulation of monocytes39,40,52,53.
After culture, monocytes were detached from wells
using cold PBS for 20min at 4 °C. Cells were then washed
and stained with 40 nM of the potentiometric mito-
chondrial probe 3, 3′-dihexyloxacarbocyanine iodide
(DiOC6(3); Invitrogen, Carlsbad, CA) and 5 µg/ml PI
(Sigma-Aldrich). After incubation for 1 h at 37 °C, cells
were analyzed, without washing steps, in a LSR Fortessa
ﬂow cytometer (BD) equipped with FACSDiva software
(BD). Debris was excluded from analysis by size and
complexity (FSC/SSC) and live cells were then gated as
live by DiOC(3)+/PI−, or exclusively PI−, using the FlowJo
X software (Tree Star Inc, Ashland, OR).
NFκB nuclear translocation analysis
Monocytes (105 cells/well) were plated on Millicell EZ
slides (Merck Millipore, Darmstadt, Germany) and
primed or not with 50 µg/ml poly(I:C) for 24 h, after
which cells were stimulated with 0.2 ng/ml LPS for 30
min. They were then washed once with PBS and ﬁxed
with PBS containing 4% paraformaldehyde (Panreac) for
30min at RT. Next, they were incubated with permeabi-
lization and blocking buffer (PB buffer; PBS containing
0.3% Triton X-100, 5% foetal bovine serum (Gibco) and
5% human AB serum (Sigma-Aldrich)) for 1 h at RT. Cells
were subsequently incubated with a poAb anti- RELA
(Cell Signaling Technology, 8242) overnight at 4 °C in PB
buffer (1/1000). Then, cells were incubated with Alexa
Fluor 647 F(ab′)2 fragment of goat anti-rabbit IgG
(Molecular Probes, A-21246) for 1 h at RT in PB buffer (1/
1000). Between steps, unbound antibodies were removed
with three washes with PBS. Finally, coverslips were
mounted in ProLong Gold Antifade reagent with DAPI
(Life Technologies), sealed and left overnight at 4 °C. The
slides were examined under an Axio Observer Z1 DUO
LSM 710 confocal system (Carl Zeiss Microscopy GmbH,
Jena, Germany) and analyzed with ZEN Black software
(Carl Zeiss Microscopy GmbH). The amount of cells with
RELA nuclear translocation was counted in at least six
different ﬁelds (>200 cells) per condition from two inde-
pendent experiments, as described54,55.
Statistical differences
Values are expressed as mean ± standard deviation. The
Kolmogorov–Smirnov analysis was used to check for
normality of data and appropriate statistical tests are
indicated for each dataset. The analyses were performed
using the Graphpad Prism (6.0 version) and differences
were considered signiﬁcant when p < 0.05. As we are
working with leucocyte residues from different human
donors, and as these primary cells have an intrinsic high
variability in the percentages of live monocytes that can be
found in vitro, we normalized the data pair-wise to best
read the effects of stimulating primed cells.
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